Skip to main content

Table 2 Number of samples per cancer type in the present analysis

From: Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs

TCGA code

Cancer type

Number of samples

BLCA

Bladder urothelial carcinoma

127

BRCA

Breast invasive carcinoma

877

COAD

Colon adenocarcinoma

380

GBM

Glioblastoma multiforme

456

HNSC

Head and neck squamous cell carcinoma

294

KIRC

Kidney renal clear cell carcinoma

433

LAML

Acute myeloid leukemia

153

LUAD

Lung adenocarcinoma

305

LUSC

Lung squamous cell carcinoma

241

OV

Ovarian serous cystadenocarcinoma

512

PRAD

Prostate adenocarcinoma

325

SKCM

Skin cutaneous melanoma

244

STAD

Stomach adenocarcinoma

163

THCA

Thyroid carcinoma

438

UCEC

Uterine corpus endometrial carcinoma

423